Ascletis Pharma (2VJ.MU) Q1 2026 Earnings

31MarConfirmed
Q1 2026
-0.03
0.3
0.63
0.97

Details

Expected EPS
-0.03459689184
Actual EPS
-0.03459689184
Surprise EPS
0
Surprise Percent
+0%

Description

Ascletis Pharma (2VJ.MU) has reported earnings of -0.03459689184 per share for Q1 2026.

0 Comments

Share your thoughts